Skip to main content
. 2021 Jun 25;17(3):260–266. doi: 10.4244/EIJ-D-19-00693

Table 3. Clinical and procedural outcomes.

Clinical and procedural outcomes
Residual stenosis ≤30% 231 (92.4)
Degree of stenosis Baseline * 81.44±7.9
Post procedure * 21.82±9.4 (p=0.021)
Ankle-brachial index Baseline 0.46±0.23
Post procedure 0.82±0.21 (p<0.001)
Follow-up 0.8±0.22 (p<0.001)
Rutherford-Becker class Baseline 3.2±0.68
Follow-up 2.04±0.64 (p<0.001)
cdTLR 34 (13.6)
Endovascular reintervention 21 (8.4)
Open, surgical treatment 13 (5.2)
Time to cdTLR (in months) 27.41±13.77
Major amputation 0
Minor amputation 2 (0.8)
Freedom from major adverse events 249 (99.6)
Values are n (%) or mean±SD. * by visual estimation. cdTLR: clinically driven target lesion revascularisation